Concepedia

Donna Mabry‐Hrones

DM

Statistics

Publications

7

Citations

325

H-Index

7

Active since

2018

Affiliations

National Cancer Institute(Current)

National Institutes of Health

Center for Cancer Research

National Heart Lung and Blood Institute

Donna Mabry‐Hrones is an author at National Cancer Institute specializing in tumor immunity, cancer therapeutics, and oncology.

Top concepts

Publications per year

2018–2023

7

Publications

7

Tremelimumab in Combination With Microwave Ablation in Patients With Refractory Biliary Tract Cancer

Changqing Xie, Austin G. Duffy, Donna Mabry‐Hrones et al. · Hepatology · 2018 · 99 citations · Full text

Immune Checkpoint Blockade in Combination with Stereotactic Body Radiotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma

Changqing Xie, Austin G. Duffy, Gagandeep Brar et al. · Clinical Cancer Research · 2020 · 96 citations · Full text

Combined immune checkpoint inhibition (ICI) with tremelimumab and durvalumab in patients with advanced hepatocellular carcinoma (HCC) or biliary tract carcinomas (BTC).

Charalampos S. Floudas, Changqing Xie, Gagandeep Brar et al. · Journal of Clinical Oncology · 2019 · 43 citations

, , +24

A Pilot Study of the PD-1 Targeting Agent AMP-224 Used With Low-Dose Cyclophosphamide and Stereotactic Body Radiation Therapy in Patients With Metastatic Colorectal Cancer

Charalampos S. Floudas, Gagandeep Brar, Donna Mabry‐Hrones et al. · Clinical Colorectal Cancer · 2019 · 42 citations · Full text

A phase I/II study of Pexa-Vec oncolytic virus in combination with immune checkpoint inhibition in refractory colorectal cancer.

M. Cecilia Monge B., Changqing Xie, Seth M. Steinberg et al. · Journal of Clinical Oncology · 2020 · 19 citations

, , +21

Rows per page

1–5 of 7